The Indian biotechnology space has the potential to grow to $100 billion in size by 2025 on the back of innovations in biomanufacturing technologies, Niti Aayog CEO Amitabh Kant said on Friday. 

Addressing a webinar titled 'Global Perspective on India's Biotech Potential: Manufacturing Hub & Foreign Investment', Kant said India is working to boost the biotechnology sector under its flagship programmes like 'Make in India' and 'Startup India'.

Kant said India has established biotechnology parks and incubators across the country to facilitate scientists and MSMEs with technology demonstration, along with pilot studies for accelerated commercial development.

In another development, Kant said real-time data would be key in fighting the coronavirus as it helps in contact tracing, which is essential for preventing further spread of the disease. 

Speaking at India Policy Forum 2020, organised by NCAER, on Friday, Kant said the government should actively put data in the public domain as debates and discussions would help in taking the right policy decisions.

Stating that the government should actively put out data before the public and academics, the Niti Aayog CEO said: "that is the only way we will be able to make right policy decisions".

(PTI)